A price target is the projected price level of a financial security stated by an investment analyst or advisor and includes assumptions of future activity. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.
News In Focus of Elanco Animal Health Incorporated:
ELAN is an exciting player in the Healthcare space, with a center of attention on Drugs – Generic.Shares of Elanco Animal Health Incorporated (ELAN) moved 0.64 % (Gain, ↑) in the last trading day finalized at the price of $29.69 on 08-02-2019 (Friday).
The relative volume of the stock is 6.41 while its market cap is $10.72B. Analysts have given a rating of 2.3 on company shares on a consensus basis. The current EPS for the company has recorded at $-0.36.
EPS growth is noticed at -617.7% for this year and anticipated -3.28% growth for next year. The company gives a ROE of 0%. The higher the ROE, the better the company is at generating profits. ROI is -4.7%.
ATR value of company was 1.07. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. Elanco Animal Health Incorporated’s latest closing price distance was -8.45% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -5.93% and -2.98% compared with the 20 Day Moving Average.
The stock price weekly volatility remained at 4.69% while volatility is standing at 3.25% for the month while A beta factor is used to measure the volatility of the stock. Beta stand at 0.
RSI after the last trading period was 40.5. Company recorded a change of 0.81% over the past week and returned -12.19% over the last three months while the company stock’s monthly performance revealed a shift in price of -8.79% .
The stock has turned around 0% yearly, so it gives a chance to investors, traders, shareholders and stakeholders to take a look at the complete situation of the market. The Company has a profit margin of 0% and an operating of 0%.
Stock price presented -21.06% negative comparing value from it 52-week high point and showed 6.04% rise in value from its 52-week low point.
The stock institutional ownership counted 20.8% while insider ownership held at 80.3%. ELAN trades at a forward P/E of 0, a P/B of 2.11, and a P/S of 3.55. The ELAN has PEG of 0.
Analyst’s mean target amount for the company is 35.53. The price at which a seller projects that a buyer will buy a product.